NMP-7

NMP-7
Identifiers
	IUPAC name (9-pentylcarbazol-3-yl)-piperidin-1-ylmethanone;
CAS Number	1358039-07-2;
PubChem CID	46871949;
ChemSpider	27470961;
CompTox Dashboard (EPA)	DTXSID901030302 ;
Chemical and physical data
Formula	C23H28N2O
Molar mass	348.480 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES c3cccc1c3n(CCCCC)c(cc2)c1cc2C(=O)N4CCCCC4;
	InChI InChI=1S/C23H28N2O/c1-2-3-7-16-25-21-11-6-5-10-19(21)20-17-18(12-13-22(20)25)23(26)24-14-8-4-9-15-24/h5-6,10-13,17H,2-4,7-9,14-16H2,1H3; Key:NZEVKZAEMSMLMC-UHFFFAOYSA-N;

NMP-7 is a drug which acts as both a non-selective agonist of the CB₁ and CB₂ cannabinoid receptors, and also as a blocker of T-type calcium channels, the target of anticonvulsant drugs such as ethosuximide. NMP-7 has an agonist EC₅₀ of 96.9nM at CB₁ and 10.5nM at CB₂, and an IC₅₀ of 1.84μM for blocking Cav3.2 T-type calcium channels. In animal studies it produces potent analgesic effects in a variety of different tests.^[1]

References

^ You H, Gadotti VM, Petrov RR, Zamponi GW, Diaz P. Functional characterization and analgesic effects of mixed cannabinoid receptor/T-type channel ligands. Molecular Pain. 2011 Nov 17;7:89. PMID 22093952

This cannabinoid related article is a stub. You can help Wikipedia by expanding it.

[1] You H, Gadotti VM, Petrov RR, Zamponi GW, Diaz P. Functional characterization and analgesic effects of mixed cannabinoid receptor/T-type channel ligands. Molecular Pain. 2011 Nov 17;7:89. PMID 22093952

[1]